상세 보기
Improved Bone and Renal Safety at 1 Year after Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF): Results from 2 Phase 3 Studies in HBeAg-positive and HBeAg-negative Patients with Chronic Hepatitis B (CHB)
- Pan, Calvin Q.;
- Brunetto, Maurizia R.;
- Hui, Aric Josun;
- Mehta, Rajiv;
- Flaherty, John F.;
- ... Kim, Hyung J.;
- 외 7명
Citations
WEB OF SCIENCE
3- 제목
- Improved Bone and Renal Safety at 1 Year after Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF): Results from 2 Phase 3 Studies in HBeAg-positive and HBeAg-negative Patients with Chronic Hepatitis B (CHB)
- 저자
- Pan, Calvin Q.; Brunetto, Maurizia R.; Hui, Aric Josun; Mehta, Rajiv; Flaherty, John F.; Suri, Vithika; Wu, George; Gaggar, Anuj; Subramanian, Mani; Nishiguchi, Shuhei; Kim, Hyung J.; Gane, Edward J.; Chuang, Wan-Long
- 발행일
- 2017-10
- 유형
- Meeting Abstract
- 저널명
- Hepatology
- 권
- 66
- 페이지
- 482A ~ 482A
- 언어
- ENG
- 출판사
- WILEY
- 발행국가
- 미국
- ISSN
- E 1527-3350
P 0270-9139